New Report Demonstrates Potential for Cell and Gene Therapies to Provide Cost Savings
January 10, 2020 11:23 ET
|
Alliance for Regenerative Medicine
WASHINGTON, D.C., Jan. 10, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- The Alliance for Regenerative Medicine (ARM), the leading international advocacy organization representing the cell and gene...
The Alliance for Regenerative Medicine Releases Initial Slate of Presenting Companies at the 2020 Cell & Gene Meeting on the Mediterranean
December 20, 2019 12:42 ET
|
Alliance for Regenerative Medicine
WASHINGTON, Dec. 20, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- The Alliance for Regenerative Medicine (ARM), the international advocacy organization for the cell and gene therapy and broader...
The Alliance for Regenerative Medicine Announces 2020 Cell & Gene Therapies State of the Industry Briefing
December 11, 2019 09:00 ET
|
Alliance for Regenerative Medicine
WASHINGTON, D.C., Dec. 11, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- The Alliance for Regenerative Medicine (ARM), the international advocacy organization representing the cell and gene therapy...
The Alliance for Regenerative Medicine Releases Q3 2019 Sector Report, Highlighting Industry Trends and Metrics
November 05, 2019 11:03 ET
|
Alliance for Regenerative Medicine
WASHINGTON, D.C., Nov. 05, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- The Alliance for Regenerative Medicine (ARM) today released its most recent quarterly sector report, offering an in-depth look...
The Alliance for Regenerative Medicine Outlines Recommendations for Increasing the Number of European-Based ATMP Clinical Trials
October 31, 2019 03:00 ET
|
Alliance for Regenerative Medicine
Europe has become less competitive than other regions in attracting new ATMP clinical trials.Faster and more streamlined review processes for clinical trials by regulatory authorities are fundamental...
The Alliance for Regenerative Medicine Announces Election of 2020 ARM Officers, Executive Committee, and Board of Directors
October 02, 2019 07:00 ET
|
Alliance for Regenerative Medicine
WASHINGTON, D.C., Oct. 02, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- The Alliance for Regenerative Medicine (ARM), the international advocacy organization for the cell and gene therapy and...
ARM and NAMCP Publish Recommendations to Increase Patient Access in Joint Study, "Roadmap for Navigating Cell and Gene Therapy Value Demonstration and Reimbursement in U.S. Managed Care"
September 24, 2019 09:00 ET
|
Alliance for Regenerative Medicine
WASHINGTON, D.C., Sept. 24, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- The Alliance for Regenerative Medicine (ARM) and the National Association of Managed Care Physicians (NAMCP) Medical...
The Alliance for Regenerative Medicine Releases Statement of Principles on Genome Editing
August 27, 2019 04:00 ET
|
Alliance for Regenerative Medicine
WASHINGTON, D.C., Aug. 27, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- The Alliance for Regenerative Medicine (ARM), the international advocacy organization representing the cell and gene therapy...
The Alliance for Regenerative Medicine Releases Q2 2019 Global Sector Report, Highlighting Industry Trends and Metrics
August 01, 2019 10:01 ET
|
Alliance for Regenerative Medicine
WASHINGTON, D.C., Aug. 01, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- The Alliance for Regenerative Medicine (ARM) today released its most recent quarterly global sector report, offering an...
The Alliance for Regenerative Medicine Releases List of Presenting Companies at the 2019 Cell & Gene Meeting on the Mesa
July 24, 2019 10:30 ET
|
Alliance for Regenerative Medicine
WASHINGTON, D.C., July 24, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- The Alliance for Regenerative Medicine (ARM), the international advocacy organization for the cell and gene therapy and...